Citation Impact
Citing Papers
Membrane-tethered mucin-like polypeptides sterically inhibit binding and slow fusion kinetics of influenza A virus
2020 StandoutNobel
Nucleic acid detection with CRISPR-Cas13a/C2c2
2017 StandoutScience
Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells
2007
Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells
2001
Ecological and immunological determinants of dengue epidemics
2006
Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses
2008
Infectious enveloped RNA virus antigenic chimeras.
1992 StandoutNobel
Microevolution and virulence of dengue viruses
2003
Sequence analysis of the membrane protein V3 of the flavivirus west nile virus and of its gene
1985
De novo design of modular and tunable protein biosensors
2021 StandoutNatureNobel
In vitro translation of 42 S virus-specific RNA from cells infected with the flavivirus west nile virus
1979
Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions
2021 StandoutNobel
Expression of Cytokine, Chemokine, and Adhesion Molecules during Endothelial Cell Activation Induced by Antibodies against Dengue Virus Nonstructural Protein 1
2005
Dengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity
2000 Standout
Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use
1988
Nucleotide sequence of dengue 2 RNA and comparison of the encoded proteins with those of other flaviviruses
1988
Cytotoxic T Lymphocytes in Dengue Virus Infection
1994
In vitro synthesis of infectious venezuelan equine encephalitis virus RNA from a cDNA clone: Analysis of a viable deletion mutant
1989
Immunopathological mechanisms in dengue and dengue hemorrhagic fever
2006
Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus
2016
Testing of a dengue 2 live-attenuated vaccine (strain 16681 PDK 53) in ten American volunteers
1996
SEC14L2 enables pan-genotype HCV replication in cell culture
2015 StandoutNatureNobel
The Global Distribution of Yellow Fever and Dengue
2006
Dengue: defining protective versus pathologic immunity
2004
In vitro assessment of human endothelial cell permeability: effects of inflammatory cytokines and dengue virus infection
2004
Analysis of the Steps Involved in Dengue Virus Entry into Host Cells
1999
Construction of Infectious cDNA Clones for Dengue 2 Virus: Strain 16681 and Its Attenuated Vaccine Derivative, Strain PDK-53
1997
Hemostatic Defects in Dengue Hemorrhagic Fever
1989
Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown
2018 StandoutNobel
Antibody, Macrophages, Dengue Virus Infection, Shock, and Hemorrhage: A Pathogenetic Cascade
1989
Analysis of specific IgM responses in secondary dengue virus infections: levels and positive rates in comparison with primary infections
2004
Host cell selection of murray valley encephalitis virus variants altered at an RGD sequence in the envelope protein and in mouse virulence
1990
Dengue Fever among Swedish Tourists
1993
Neutralization and Antibody-Dependent Enhancement of Dengue Viruses
2003
The Outbreak of West Nile Virus Infection in the New York City Area in 1999
2001
Fusion activity of flaviviruses: comparison of mature and immature (prM-containing) tick-borne encephalitis virions
1991
Nucleotide sequence of the virulent SA-14 strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA-14-14-2
1990
Receptors and routes of dengue virus entry into the host cells
2015
Complete nucleotide sequence of the Japanese encephalitis virus genome RNA
1987
Determinants of Inapparent and Symptomatic Dengue Infection in a Prospective Study of Primary School Children in Kamphaeng Phet, Thailand
2011
Factors Affecting Reproducibility between Genome-Scale siRNA-Based Screens
2010
Analysis of a Yellow Fever Virus Isolated from a Fatal Case of Vaccine-Associated Human Encephalitis
1994
Supernatants from dengue virus type‐2 infected macrophages induce permeability changes in endothelial cell monolayers
2003
The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution
1995 StandoutNature
Early Clinical and Laboratory Indicators of Acute Dengue Illness
1997
Dengue 1 virus binding to human hepatoma HepG2 and simian Vero cell surfaces differs
1996
Pathogenesis of dengue virus diseases: missing pieces in the jigsaw
1997
Molecular Characterization of a Neutralizing Domain of the Japanese Encephalitis Virus Structural Glycoprotein
1989
Dengue: an update
2002
The global distribution and burden of dengue
2013 StandoutNature
Molecular evolution and distribution of dengue viruses type 1 and 2 in nature
1990
Dengue: a continuing global threat
2010 Standout
Diclofenac residues as the cause of vulture population decline in Pakistan
2004 StandoutNature
Genetic variation and microevolution of dengue 2 virus in Southeast Asia
1989
A Wolbachia Symbiont in Aedes aegypti Limits Infection with Dengue, Chikungunya, and Plasmodium
2009 Standout
Mouse models of dengue virus infection and disease
2008
Synthetic peptides derived from the deduced amino acid sequence of the E-glycoprotein of Murray Valley encephalitis virus elicit antiviral antibody
1989
Intrinsic Immunity Shapes Viral Resistance of Stem Cells
2017 StandoutNobel
Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks
2002
Processing, secretion, and immunoreactivity of carboxy terminally truncated dengue-2 virus envelope proteins expressed in insect cells by recombinant baculoviruses
1991
Production of yellow fever virus proteins in infected cells: Identification of discrete polyprotein species and analysis of cleavage kinetics using region-specific polyclonal antisera
1990
Zika Virus Outbreak on Yap Island, Federated States of Micronesia
2009 Standout
Immunogenicity of a Purified Fragment of 170 Yellow Fever Envelope Protein
1990
Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever
1999
The Synthesis and Maturation of a Non-structural Extracellular Antigen from Tick-borne Encephalitis Virus and Its Relationship to the Intracellular NS1 Protein
1989
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Do escape mutants explain rapid increases in dengue casefatality rates within epidemics?
2000
Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213
1995 StandoutNobel
Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection
1991
Analyses of the terminal sequences of west nile virus structural proteins and of the in vitro translation of these proteins allow the proposal of a complete scheme of the proteolytic cleavages involved in their synthesis
1989
Virus-induced autoantibody response to a transgenic viral antigen
1990 StandoutNatureNobel
HIV as the cause of AIDS
1996 StandoutNobel
Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody
2009
Human skin Langerhans cells are targets of dengue virus infection
2000
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Construction of a Full Length Infectious Clone for Dengue-1 Virus Western Pacific,74 Strain
2000
Localization of Dengue Virus in Naturally Infected Human Tissues, by Immunohistochemistry and In Situ Hybridization
2004
Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting
1997
Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice
1997
High Levels of Plasma Dengue Viral Load during Defervescence in Patients with Dengue Hemorrhagic Fever: Implications for Pathogenesis
2003
A Focus of Deer Tick Virus Transmission in the Northcentral United States
1999
Immunopathogenesis of Dengue Hemorrhagic Fever
1999
Single Amino Acid Codon Changes Detected in Louping Ill Virus Antibody-Resistant Mutants with Reduced Neurovirulence
1993
Report of a fatal case of dengue infection with hepatitis: Demonstration of dengue antigens in hepatocytes and liver apoptosis
1999
Dengue Virus Infects Macrophages and Dendritic Cells in a Mouse Model of Infection
2007
The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity
2010
Antibodies from dengue patient sera cross‐react with endothelial cells and induce damage
2002
Dengue virus infection of human microvascular endothelial cells from different vascular beds promotes both common and specific functional changes
2005
Vascular Leakage in Severe Dengue Virus Infections: A Potential Role for the Nonstructural Viral Protein NS1 and Complement
2006
Origins of Dengue Type 2 Viruses Associated with Increased Pathogenicity in the Americas
1997
Antibodies to dengue 2 virus E-glycoprotein synthetic peptides identify antigenic conformation
1990
Dengue virus: molecular basis of cell entry and pathogenesis, 25–27 June 2003, Vienna, Austria
2004
TMEM41B Is a Pan-flavivirus Host Factor
2020 StandoutNobel
Antibody-mediated neutralization of flaviviruses: A reductionist view
2011
rDEN4Δ30, a Live Attenuated Dengue Virus Type 4 Vaccine Candidate, Is Safe, Immunogenic, and Highly Infectious in Healthy Adult Volunteers
2005
Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission.
2001
SARS-CoV-2 vaccines in development
2020 StandoutNature
Dengue diagnosis, advances and challenges
2004
A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates
2006
Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells
1992 StandoutNobel
Prospects for a dengue virus vaccine
2007
Dengue
2007 Standout
Dengue Virus Infection of Human Endothelial Cells Leads to Chemokine Production, Complement Activation, and Apoptosis
1998
West Nile Virus: Epidemiology and Ecology in North America
2003
Dengue 4 Virus Monoclonal Antibodies Identify Epitopes that Mediate Immune Infection Enhancement of Dengue 2 Viruses
1987
The Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and Immunoprophylaxis
2017
DC-SIGN (CD209) Mediates Dengue Virus Infection of Human Dendritic Cells
2003 StandoutNobel
Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection
1977
Altered Enzyme-Linked Immunosorbent Assay Immunoglobulin M (IgM)/IgG Optical Density Ratios Can Correctly Classify All Primary or Secondary Dengue Virus Infections 1 Day after the Onset of Symptoms, when All of the Viruses Can Be Isolated
2006
Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes
1997
Partial nucleotide sequence of St. Louis encephalitis virus RNA: Structural proteins, NS1, ns2a, and ns2b
1987 StandoutNobel
Proteins specified by group B togaviruses in mammalian cells during productive infections
1973
Demonstration of concurrent dengue 1 and dengue 3 infection in six patients by the polymerase chain reaction
1991
Partial Agonist Effect Influences the CTL Response to a Heterologous Dengue Virus Serotype
1999
Replication of the flavivirus Kunjin: Proteins, glycoproteins, and maturation associated with cell membranes
1976
Human Dendritic Cells as Targets of Dengue Virus Infection
2001
Infection of cultured rat hepatoma cells by mouse mammary tumor virus
1977
Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it.
1987 StandoutNobel
Identification of Proteins Bound to Dengue Viral RNA In Vivo Reveals New Host Proteins Important for Virus Replication
2016
Nucleotide Sequence of Yellow Fever Virus: Implications for Flavivirus Gene Expression and Evolution
1985 StandoutScienceNobel
Antibody-Enhanced Infection by HIV-1 Via Fc Receptor-Mediated Entry
1988 Science
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
1995 StandoutScience
Synthesis of Proteins and Glycoproteins in Dengue Type 2 Virus-infected Vero and Aedes albopictus Cells
1985
Zika virus activates de novo and cross-reactive memory B cell responses in dengue-experienced donors
2017
An Antigen Capture Enzyme-Linked Immunosorbent Assay Reveals High Levels of the Dengue Virus Protein NS1 in the Sera of Infected Patients
2000
Dengue Virus–Mosquito Interactions
2007
Partial sequence analysis of cloned dengue virus type 2 genome
1986
Modulation of Dengue Virus Infection in Human Cells by Alpha, Beta, and Gamma Interferons
2000
Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody
1977
Evaluation of a dipstick enzyme-linked immunosorbent assay for detection of antibodies to dengue virus
1997
PHASE I TRIAL OF 16 FORMULATIONS OF A TETRAVALENT LIVE-ATTENUATED DENGUE VACCINE
2003
Nucleotide sequence of the 26S mRNA of Sindbis virus and deduced sequence of the encoded virus structural proteins.
1981 StandoutNobel
Tropism of Dengue Virus in Mice and Humans Defined by Viral Nonstructural Protein 3-Specific Immunostaining
2009
Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro
2012 StandoutNobel
Antibody-mediated Early Death in vivo after Infection with Yellow Fever Virus
1986
Nucleotide sequence and deduced amino acid sequence of the structural proteins of dengue type 2 virus, Jamaica genotype
1986
Comparison of replication rates and pathogenicities between the SA 14 parent and SA 14-14-2 vaccine strains of Japanese encephalitis virus in mouse brain neurons
1993
Endothelial Cell Apoptosis Induced by Antibodies Against Dengue Virus Nonstructural Protein 1 Via Production of Nitric Oxide
2002
Structural basis of potent Zika–dengue virus antibody cross-neutralization
2016 Nature
Envelope Protein of the Flavivirus Kunjin is Apparently Not Glycosylated
1982
Pathology of Fatal West Nile Virus Infections in Native and Exotic Birds during the 1999 Outbreak in New York City, New York
2000
Detection of circulant tumor necrosis factor-alpha , soluble tumor necrosis factor p75 and interferon-gamma in Brazilian patients with dengue fever and dengue hemorrhagic fever
2001
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
The Human Antibody Response to Dengue Virus Infection
2011
Cloning full-length dengue type 4 viral DNA sequences: Analysis of genes coding for structural proteins
1986
Nucleotide sequence of the 26 S mRNA of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and deduced sequence of the encoded structural proteins
1986
Nonstructural proteins nsP3 and nsP4 of Ross River and O'Nyong-nyong viruses: Sequence and comparison with those of other alphaviruses
1988 StandoutNobel
Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model
1989
Rapid identification of dengue virus serotypes by using polymerase chain reaction
1991
Dengue Plaque Reduction Neutralization Test (PRNT) in Primary and Secondary Dengue Virus Infections: How Alterations in Assay Conditions Impact Performance
2009
Complement receptor mediates enhanced flavivirus replication in macrophages.
1983
Studies on virus-specific nucleic acids synthesized in vertebrate and mosquito cells infected with flaviviruses
1978
Complex-specific immunoglobulin M antibody patterns in humans infected with alphaviruses
1986
Sequence analysis of the viral core protein and the membrane-associated proteins V1 and NV2 of the flavivirus west nile virus and of the genome sequence for these proteins
1985
Protection of Mice Against Dengue 2 Virus Encephalitis by Immunization with the Dengue 2 Virus Non-structural Glycoprotein NS1
1987
Isolation of Dengue Viruses from Peripheral Blood Leukocytes of Patients with Hemorrhagic Fever
1980
Identification of epitopes on the E glycoprotein of Saint Louis encephalitis virus using monoclonal antibodies
1983
Genetic variation among dengue 2 viruses of different geographic origin
1983
Immunofluorescent sites in vero cells infected with the flavivirus Kunjin
1983
Identification of Saint Louis encephalitis virus mRNA
1978
Amino-terminal amino acid sequences of structural proteins of three flaviviruses
1985
Isolation of dengue viruses by intracerebral inoculation of mosquito larvae
1986
Alphavirus-based expression vectors: strategies and applications.
1996 StandoutNobel
Comparison of four reverse transcription-polymerase chain reaction procedures for the detection of dengue virus in clinical specimens
2002
Partial nucleotide sequence of the Japanese encephalitis virus genome
1987
Emerging Infectious Diseases of Wildlife-- Threats to Biodiversity and Human Health
2000 StandoutScience
A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells.
1996 StandoutNobel
Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus
2016
Phase 1 Trial of the Dengue Virus Type 4 Vaccine Candidate rDEN4Δ30-4995 in Healthy Adult Volunteers
2009
An electron and immunoelectron microscopic study of dengue-2 virus infection of cultured mosquito cells: Maturation events
1987
Antigenic characterization of flavivirus structural proteins separated by isoelectric focusing
1977
Posttransfusion non-A, non-B hepatitis in chimpanzees. Physicochemical evidence that the tubule-forming agent is a small, enveloped virus.
1985
Primary structure of the West Nile flavivirus genome region coding for all nonstructural proteins
1986
Peptide Inhibitors of Flavivirus Entry Derived from the E Protein Stem
2010
Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody
2017
Pathogenesis of human immunodeficiency virus infection
1993
Antigenic characterization of two Sindbis envelope glycoproteins separated by isoelectric focusing
1976
Genetic and Epidemiological Studies of Dengue Type 2 Viruses by Hybridization Using Synthetic Deoxyoligonucleotides as Probes
1986
Construction of intertypic chimeric dengue viruses by substitution of structural protein genes.
1991
Suppression of lipopolysaccharide-induced antiviral transcription factor (STAT-1 and NF-κB) complexes by antibody-dependent enhancement of macrophage infection by Ross River virus
2002
Neutralizing Antibodies after Infection with Dengue 1 Virus
2007
Glucocorticoid-stimulated accumulation of mouse mammary tumor virus RNA: increased rate of synthesis of viral RNA.
1977 StandoutNobel
Antibody-Dependent Enhancement of Viral Infectivity
1986
Potential Application of Nonstructural Protein NS1 Serotype-Specific Immunoglobulin G Enzyme-Linked Immunosorbent Assay in the Seroepidemiologic Study of Dengue Virus Infection: Correlation of Results with Those of the Plaque Reduction Neutralization Test
2002
Newly synthesized dengue-2 virus nonstructural protein NS1 is a soluble protein but becomes partially hydrophobic and membrane-associated after dimerization
1989
Antibody-enhanced dengue virus infection in primate leukocytes
1977 Nature
Lethal 17D Yellow Fever Encephalitis in Mice. I. Passive Protection by Monoclonal Antibodies to the Envelope Proteins of 17D Yellow Fever and Dengue 2 Viruses
1986
Structural and Nonstructural Proteins of Saint Louis Encephalitis Virus
1971
Analysis of disulfides present in the membrane proteins of the West Nile flavivirus
1987
Bacterial Lipopolysaccharide Inhibits Dengue Virus Infection of Primary Human Monocytes/Macrophages by Blockade of Virus Entry via a CD14-Dependent Mechanism
1999
Flow Cytometry-Based Assay for Titrating Dengue Virus
2005
IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers
2004
Flow Cytometry Compared with Indirect Immunofluorescence for Rapid Detection of Dengue Virus Type 1 after Amplification in Tissue Culture
2001
Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5' untranslated region and poly(A) tails at the 3' end.
1991 StandoutNobel
MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells
2006
Study of the distribution of antibody‐ dependent enhancement determinants on dengue 2 isolates using dengue 2‐derived monoclonal antibodies
1987
Partial nucleotide sequence of the Murray Valley encephalitis virus genome
1986 StandoutNobel
Strategy of the flavivirus genome: Evidence for multiple internal initiation of translation of proteins specified by Kunjin virus in mammalian cells
1977
Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis
1988
Bayesian Inference of Phylogeny and Its Impact on Evolutionary Biology
2001 StandoutScience
Detection of Dengue Viral RNA Using a Nucleic Acid Sequence-Based Amplification Assay
2001
Amino acid compositions and amino-terminal sequences of the structural proteins of a flavivirus, European Tick-Borne encephalitis virus
1983
Evaluation of an Enzyme Immunoassay for Detection of Dengue Virus NS1 Antigen in Human Serum
2006
Yellow Fever/Japanese Encephalitis Chimeric Viruses: Construction and Biological Properties
1999 StandoutNobel
Update on Powassan Virus: Emergence of a North American Tick-Borne Flavivirus
2009
Dengue Hemorrhagic Fever in Infants: Research Opportunities Ignored
2002
Pathogen-derived resistance to dengue type 2 virus in mosquito cells by expression of the premembrane coding region of the viral genome
1996
Induction of interferon alpha from human lymphocytes by autologous, dengue virus-infected monocytes.
1987
Use and Abuse of RNAi to Study Mammalian Gene Function
2012 StandoutScienceNobel
Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization
1985
Dengue Virus Type 2 Vaccine: Reactogenicity and Immunogenicity in Soldiers
1984
Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis.
1990 StandoutNobel
Dynamic effects of antibody-dependent enhancement on the fitness of viruses
2005
Protease treatment and chemical crosslinking of a Flavivirus: Tick borne encephalitis virus
1979
The Biology and Detection of Immune Complexes
1980
Selective Primary Health Care: Strategies for Control of Disease in the Developing World. XI. Dengue
1984
Geographic classification of dengue-2 virus strains by antigen signature analysis
1986
Synthesis of glycoproteins in cells infected by the flavivirus Kunjin
1981
Construction and characterization of chimeric tick-borne encephalitis/dengue type 4 viruses.
1992
Bibliography on pathogens of medically important arthropods: 1980.
1980
Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody
2020 StandoutNobel
Protective monoclonal antibodies define maturational and pH-dependent antigenic changes in sindbis virus E1 glycoprotein
1983
Type- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent Epitopes
2007
Genetic determinants of dengue type 4 virus neurovirulence for mice
1993
Passive immunotherapy in AIDS: a double-blind randomized study based on transfusions of plasma rich in anti-human immunodeficiency virus 1 antibodies vs. transfusions of seronegative plasma.
1995 StandoutNobel
Heterogeneity among flavivirus proteins separated in slab gels
1977
Noncytopathic Sindbis virus RNA vectors for heterologous gene expression
1998 StandoutNobel
Flavivirus Infection Enhancement in Macrophages: Radioactive and Biological Studies on the Effect of Antibody on Viral Fate
1984
Epitope Mapping of Flavivirus Glycoproteins
1986
Pathogenesis of dengue: challenges to molecular biology
1988 Science
Cell-associated West Nile flavivirus is covered with E+pre-M protein heterodimers which are destroyed and reorganized by proteolytic cleavage during virus release
1989
Population dynamics of flaviviruses revealed by molecular phylogenies.
1996
Serologic Tools and Strategies to Support Intervention Trials to Combat Zika Virus Infection and Disease
2019
DENGUE IN THE WESTERN HEMISPHERE
1994
Advances in dengue diagnosis
1996
Dengue and Dengue Hemorrhagic Fever
1998 Standout
Pathogenesis of Dengue: Challenges to Molecular Biology
1988 StandoutScience
Monkeys immunized with intertypic chimeric dengue viruses are protected against wild-type virus challenge
1996
Virion and soluble antigens of japanese encephalitis virus
1975
Enhancement of the antibody response to flavivirus B-cell epitopes by using homologous or heterologous T-cell epitopes
1992
ANALYSIS OF RECOMBINANT DENGUE VIRUS POLYPEPTIDES FOR DENGUE DIAGNOSIS AND EVALUATION OF THE HUMORAL IMMUNE RESPONSE
2004
An evolutionary tree relating eight alphaviruses, based on amino-terminal sequences of their glycoproteins.
1984
Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein.
1990 StandoutNobel
Antibody-dependent enhancement and vaccine development
2006
Posttransfusion non-A, non-B hepatitis in chimpanzees
1985
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
1989 StandoutScienceNobel
Works of Walter E. Brandt being referenced
Antibody-Dependent Enhancement of Dengue Virus Growth in Human Monocytes as a Risk Factor for Dengue Hemorrhagic Fever
1989
Antigenic Relationships between Flaviviruses as Determined by Cross-neutralization Tests with Polyclonal Antisera
1989
Current Approaches to the Development of Dengue Vaccines and Related Aspects of the Molecular Biology of Flaviviruses
1988
Development of Dengue and Japanese Encephalitis Vaccines
1990
Dengue-2 Vaccine: Infection of Aedes aegypti Mosquitoes by Feeding on Viremic Recipients
1982
Replication of dengue and junin viruses in cultured rabbit and human endothelial cells
1978
Isolation of a temperature-sensitive dengue-2 virus under conditions suitable for vaccine development
1976
Cytological Localization of Dengue-2 Antigens: an Immunological Study with Ultrastructural Correlation
1973
Partial Purification and Characterization of a Dengue Virus Soluble Complement-Fixing Antigen
1970
Membrane-bound proteins of Japanese encephalitis virus-infected chick embryo cells
1972
The proteins of Japanese encephalitis virus
1971
Lysis of dengue virus-infected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity
1984
Identification of Distinct Antigenic Determinants on Dengue-2 Virus Using Monoclonal Antibodies
1982
Effect of Passage History on Dengue-2 Virus Replication in Subpopulations of Human Leukocytes
1979
Evidence for two mechanisms of dengue virus infection of adherent human monocytes: trypsin-sensitive virus receptors and trypsin-resistant immune complex receptors
1981
Change involving a viral membrane glycoprotein during morphogenesis of group B arboviruses
1972
RNA Fingerprinting as a Method for Distinguishing Dengue 1 Virus Strains
1983
Molecular size and charge relationships of the soluble complement-fixing antigens of dengue viruses
1970
Replication of Dengue-2 Virus in Cultured Human Lymphoblastoid Cells and Subpopulations of Human Peripheral Leukocytes
1976
Dengue Virus-Specific and Flavivirus Group Determinants Identified with Monoclonal Antibodies by Indirect Immunofluorescence
1982
Identification of an Antigenic and Genetic Variant of Dengue-4 Virus from the Caribbean
1986
Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants
1982
Detection of Dengue Cell-Surface Antigens by Peroxidase-Labeled Antibodies and Immune Cytolysis
1974
Comparison of the Virion Polypeptides of Group B Arboviruses
1972
Morphology and development of dengue-2 virus employing the freeze-fracture and thin-section techniques
1974
Immunological and Biophysical Separation of Dengue-2 Antigens
1971
Immunoprecipitation Analysis of Soluble Complement-Fixing Antigens of Dengue Viruses
1970
Epitopic Analysis of Antigenic Determinants on the Surface of Dengue-2 Virions Using Monoclonal Antibodies *
1985
Physical and Biological Properties of Dengue-2 Virus and Associated Antigens
1970
Production and Characterization of Arbovirus Antibody in Mouse Ascitic Fluid
1967
Proposed Antigenic Classification of Registered Arboviruses I. Togaviridae, <i>Alphavirus</i>
1980
Dengue Virions and Antigens in Brain and Serum of Infected Mice
1970
Separation of Dengue Strains on the Basis of a Nonstructural Antigen
1971
Rapid Identification of Dengue Virus Isolates by using Monoclonal Antibodies in an Indirect Immunofluorescence Assay
1983